Rothschild Investment »

Cartesian Therapeutics shares owned by Rothschild Investment

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Rothschild Investment from 13F filings

Historical chart of Rothschild Investment investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Rothschild Investment consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Rothschild Investment

Quarter filed Position value Share count Share price at filing
2026-03-31 $246 40 6.15

More positions owned by Rothschild Investment

Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Jpmorgan Chase & Co Stock (JPM)
Invesco Rafi Us 1000 Etf Etf (PRF)
Berkshire Hathaway Inc Del Cl B Stock (BRK.B)
Amazon Stock (AMZN)
Microsoft Corp Stock (MSFT)
Alphabet Inc Cap Stk Cl C Stock (GOOG)
Exxon Mobil Corp Stock (XOM)
Johnson & Johnson Stock (JNJ)
Capital Group Dividend Growers Etf Etf (CGDG)
Blackstone Stock (BX)
Abbvie Stock (ABBV)
Chevron Corporation Stock (CVX)

View all positions for Rothschild Investment

Top funds holding Cartesian Therapeutics

Squarepoint Ops
FMR
BlackRock
Vanguard Group
Vanguard Capital Management
683 Capital Management
Millennium Management
Geode Capital Management
Erste Asset Management GmbH
State Street Corporation
Privium Fund Management B.V.
Marshall Wace
Two Sigma Investments
UBS Group
Citadel Advisors

View all funds holding Cartesian Therapeutics